The Doctoral School of the Maj Institute of Pharmacology of the Polish Academy of Sciences (DS IP PAS) was established in 2023 by order of the Director of the Institute of Pharmacology PAS (IF PAN). The School commenced its educational activities in 2024, and currently 12 doctoral students are pursuing their studies: 3 in their first year, 3 in their second year, and 6 in their third year. The School has an international character, with one foreign national currently enrolled at DS IP PAS.

The establishment of DS IP PAS was driven by the need to train doctoral students capable of addressing one of the greatest civilizational challenges of our time, namely the steady rise in the incidence of psychiatric and neurodegenerative diseases. The key health problem areas in Poland outlined in the national healthcare system development strategy “Healthy Future” (Zdrowa przyszłość) for 2021–2027, with a perspective until 2030, indicate that nervous system disorders, psychiatric disorders (depression), and neurodegenerative diseases (Alzheimer’s disease, Parkinson’s disease, and other dementias) rank 5th among the most common health disorders and, due to civilizational changes, are beginning to affect increasingly younger individuals. This creates a necessity to search for and develop new, effective therapies, as well as to answer questions regarding the etiology of these diseases and their prevention, particularly during childhood and adolescence.

DS IP PAS provides education in the field of medical sciences and health sciences in two disciplines: medical sciences and pharmaceutical sciences. The research directions pursued at DS IP PAS are primarily aimed at graduates with higher education in medicine, pharmacy, biology, biotechnology, chemistry, or related fields. The curriculum and scientific research topics respond to the needs of our time and focus on the development of new therapies for neurodegenerative, psychiatric, and neurological diseases. The research topics carried out by DS IP PAS doctoral students cover the design of new biologically active substances, the determination of their physicochemical properties, and their potential pharmacological and therapeutic applications. A significant part of the research also concerns the etiology and pathomechanism of nervous system diseases and possibilities for their prevention.

Education at DS IP PAS is conducted by a highly qualified academic staff of IF PAN, possessing many years of experience and outstanding achievements in experimental neuropsychopharmacology and neurobiology, as well as in the search for new biologically active substances and potential drugs. Doctoral students not only attend thematic classes offered by DS IP PAS, but also participate in numerous conferences, such as the Winter School (Szkoła Zimowa), the symposium celebrating the 70th anniversary of IF PAN, the Paneris School, the CEBC Congress, and the Second Polish Pharmacology Days (Drugie Dni Farmakologii Polskiej). This gives them the opportunity to get to know the scientific community, engage in scientific discussions with experts in the field, and exchange scientific ideas.

DS IP PAS offers opportunities for scientific development and education covering the entire pathway of developing modern therapies—from the creation of a new chemical molecule to its application in experimental animal models to test its pharmacological and potential therapeutic efficacy.

 

Head of the Doctoral School of the Maj Institute of Pharmacology of the Polish Academy of Sciences:

Deputy Head of the Doctoral School of the Maj Institute of Pharmacology of the Polish Academy of Sciences:

Doctoral Education Officer:

Fundusze Europejskie Inteligentny Rozwój Rzeczpospolita Polska Fundacja na rzecz Nauki Polskiej Unia Europejska Europejski Fundusz Rozwoju Regionalnego Ministerstwo Nauki i Szkolnictwa Wyższego Polska Akademia Nauk